SOLATENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Solatene, and what generic alternatives are available?
Solatene is a drug marketed by Roche and is included in one NDA.
The generic ingredient in SOLATENE is beta carotene. There are two hundred and ten drug master file entries for this compound. Additional details are available on the beta carotene profile page.
Summary for SOLATENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Patent Applications: | 67 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SOLATENE at DailyMed |
US Patents and Regulatory Information for SOLATENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | SOLATENE | beta carotene | CAPSULE;ORAL | 017589-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |